The GPD will lead all aspects of Patient Marketing & Strategy across the INLEXZO™ brand in the U.S. Bladder Cancer market, continuing with the launch of the brand’s first indication, and preparing for at least two more in close proximity.
Must-have
Nice-to-have
Not specified